Chris Wheatcroft
Chris is an Investment Partner at the Ascension Life Fund and runs the operational aspects of the fund. He is an entrepreneur turned investor and has 12 years of experience in the early stage investment market. He has completed over 170 transactions during his career and has run funds for both Ascension and Angels Den.
The Ascension Life Fund is a TechBio fund that invests into technology companies that are disrupting the pharma industry. The rationale for this is that the Fund understands the pharma industry very well, sales cycles are relatively short and the opportunity for companies to exit is significant.
The fund invests at the intersection of cutting-edge technologies and life sciences with four defined themes: Multi-Omics (inc. Biomarkers & Diagnostics), Healthcare Data & Platforms, Medical Devices and Pharma Value Chain.